Supplementary

Business

Supplementary Review: Dave & Buster’s (PLAY), June 13, 2024

Fiscal 2024 Q1 revenue fell 1.5% year-on-year to $588.1 million as a 5.6% drop in comparable store sales was mostly…

Read More »
Business

Supplementary Review: SpartanNash (SPTN), June 3, 2024

Q1 net sales fell 3.5% year-over-year to $2.81 billion. By segment, Wholesale sales declined 3.4% to $2.01 billion due primarily…

Read More »
Business

Supplementary Review: Health Catalyst (HCAT), May 14, 2024

HCAT reported a 1.2% year-over-year increase in first quarter revenue to $74.7 million. With Technology segment sales essentially flat at…

Read More »
Business

Supplementary Review: IBEX Limited (IBEX), May 13, 2024

In our view, this continues to highlight IBEX’s ability to leverage its superior and more cost-effective solutions to win new…

Read More »
Business

Supplementary Review: Cambium Networks (CMBM), May 13, 2024

Given CMBM’s less-than-impressive operating performance in recent quarters, we understand why the market would be skeptical. But with the two…

Read More »
Business

Supplementary Review: American Vanguard (AVD), May 10, 2024

Net sales in the first quarter of 2024 rose 8.2% year-over-year to $135.1 million with all of its businesses contributing…

Read More »
Business

Supplementary Review: RCM Technologies (RCMT), May 9, 2024

RCMT reported revenue of $71.9 million for the first quarter of 2024, which was up 7.2% from the prior year.…

Read More »
Business

Supplementary Review: AudioCodes (AUDC), May 7, 2024

AUDC reported a 1.5% year-over-year rise in Q1 revenue to $60.1 million. While Products segment revenue fell 0.5% to $28.6…

Read More »
Business

Supplementary Review: ACCO Brands (ACCO), May 6, 2024

Hurt by an 11.3% decline in comparable sales, net sales in the first quarter of 2024 were down 10.9% from…

Read More »
Business

Supplementary Review: Avanos Medical (AVNS), May 3, 2024

Buoyed by organic growth of 9% in Digestive Health, which benefited from the persistence of strong demand for NeoMed from…

Read More »
Back to top button